In last years, heroin-addicted have exponentially increased: this has made it necessary to identify a pharmacological strategy as effective as possible. With this purpose, a statistical investigation was conducted in a sample of individuals, aged between 18 and 50.They were diagnosed and subjected to different treatments at Ser.T of Caltanissetta (Sicily-Italy) during the period 2013-2017. The analyzed patients were treated with three different pharmacological therapy: methadone 0.1%, methadone 0.5%, buprenorphine and suboxone. We obtained percentages of responders, low responders and non-responders patients from data processing, based on used therapy. Considering pharmacological responses of the sample examined, it is possible to observe that the treatment with buprenorphine has led to 71.98% of responders subjects, 23.52% of low responders and 4.5% of non-responders. Instead, the administration of methadone 0.1 % has produced 82.82% of responders subjects, 11.08% of low responders, 6.1% of nonresponders. The therapy with methadone 0.5% has resulted 88.98% of responders subjects, 7.8% of low responders, 3.22% of nonresponders. Finally, through the administration of suboxone, we obtained 86.34% of responders subjects, 9.84% of low responders and 3.82% of non responders. In conclusion, although it has emerged that treatment with methadone 0.5% is the most successful therapy, it is preferable to use suboxone (except in relapsing subjects) since it has also produced a high number of responders subjects and a good safety profile for heroin addicted patients.

Fabio Venturella, G.C. (2020). Methadone versus buprenorphine data detected from Caltanissetta SER.T. JOURNAL OF BIOLOGICAL RESEARCH, 93(1), 22-24 [10.4081/jbr.2020.8345].

Methadone versus buprenorphine data detected from Caltanissetta SER.T

Fabio Venturella
Investigation
;
Marco Giammanco
Investigation
;
2020

Abstract

In last years, heroin-addicted have exponentially increased: this has made it necessary to identify a pharmacological strategy as effective as possible. With this purpose, a statistical investigation was conducted in a sample of individuals, aged between 18 and 50.They were diagnosed and subjected to different treatments at Ser.T of Caltanissetta (Sicily-Italy) during the period 2013-2017. The analyzed patients were treated with three different pharmacological therapy: methadone 0.1%, methadone 0.5%, buprenorphine and suboxone. We obtained percentages of responders, low responders and non-responders patients from data processing, based on used therapy. Considering pharmacological responses of the sample examined, it is possible to observe that the treatment with buprenorphine has led to 71.98% of responders subjects, 23.52% of low responders and 4.5% of non-responders. Instead, the administration of methadone 0.1 % has produced 82.82% of responders subjects, 11.08% of low responders, 6.1% of nonresponders. The therapy with methadone 0.5% has resulted 88.98% of responders subjects, 7.8% of low responders, 3.22% of nonresponders. Finally, through the administration of suboxone, we obtained 86.34% of responders subjects, 9.84% of low responders and 3.82% of non responders. In conclusion, although it has emerged that treatment with methadone 0.5% is the most successful therapy, it is preferable to use suboxone (except in relapsing subjects) since it has also produced a high number of responders subjects and a good safety profile for heroin addicted patients.
Settore BIO/14 - Farmacologia
http://www.jbiolres.org/
Fabio Venturella, G.C. (2020). Methadone versus buprenorphine data detected from Caltanissetta SER.T. JOURNAL OF BIOLOGICAL RESEARCH, 93(1), 22-24 [10.4081/jbr.2020.8345].
File in questo prodotto:
File Dimensione Formato  
Methadone versus buprenorphine data detected from Caltanissetta SER.T.pdf

accesso aperto

Descrizione: Aritcolo principale
Tipologia: Versione Editoriale
Dimensione 471.17 kB
Formato Adobe PDF
471.17 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/427644
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact